bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.01.24.525291

Lung-mimicking hydrogel culture system reproduces several tuberculosis phenotypes and demonstrates pyrazinamide efficacy

Kolluru, G. V. G.·S., A. P.·M., J. K.·Jeyasankar, S.·Raghunathan, V.·Agarwal, R.
View original source ↗Export metadata ↓

Abstract

Faithful mimics of tuberculosis (TB) infection are needed to provide mechanistic insights into the complex host-pathogen interactions and accelerate drug discovery. Current in vitro models only allow short investigation durations, present divergent transcriptional signatures to human infections, and are unreliable drug discovery platforms. We developed a 3D collagen culture system mimicking the lung microenvironment (collagen fibres, pore size and stiffness), where we incorporated Mycobacterium tuberculosis (Mtb) infected human THP-1 or primary monocytes. Dual RNA-sequencing revealed high mammalian gene expression similarity with patient samples compared to 2D macrophage infections. Similarly, gene expression of bacteria was much more representative to in vivo gene expression compared to bacteria in 2D cultures (114 genes in 3D vs 21 genes in 2D). Key phenotypes observed in humans, such as foamy macrophages and mycobacterial cords (never seen in any other in vitro culture system), were reproduced in our model. Our system overcomes many challenges associated with the traditional platforms, including showing remarkable efficacy with clinically relevant concentrations of first-line anti-TB drug pyrazinamide, not seen in any other in vitro model, making it reliable, readily adoptable for tuberculosis studies and drug screening. Significance statementMtb is a slow-growing pathogen which modulates host response over time. The current in vitro platforms offer a very short study duration to study, are unreliable as drug discovery platforms, and the phenotypic and genotypic traits of the host and pathogen differ. The collagen-I hydrogel culture system developed in this study addresses these challenges by successfully recapitulating several key phenotypes observed in human infections. Dual RNA sequence also showed excellent gene expression similarities for both the host and the bacteria. Furthermore, remarkable efficacy with the antibiotic Pyrazinamide was demonstrated, a first for in vitro cultures despite over 50 years of clinical use of the drug. We expect our platform to be exploited widely for drug discovery and understanding host-pathogen interactions.

Source connections

Explore related subjects

bioengineeringPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kolluru, G. V. G., S., A. P., M., J. K., Jeyasankar, S., Raghunathan, V., Agarwal, R.. 2023-01-25. Lung-mimicking hydrogel culture system reproduces several tuberculosis phenotypes and demonstrates pyrazinamide efficacy. https://doi.org/10.1101/2023.01.24.525291

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Synergy-informed bilevel optimization reveals joint-specific benefits for realistic exoskeleton torque prediction

Simulation-driven optimization can guide exoskeleton control design, but its utility is limited by the accuracy with which muscle coordination is predicted. Strict effort-minimization formulations predict non-physiological muscle shutdown under high exoskeleton assistance, leading to peak assistive torques that exceed values reported in human-in-the-loop experiments. We evaluated the accuracy of synergy-informed simulations at predicting assistance across four single-joint exoskeleton configurations: ankle plantarflexion, knee extension, hip flexion, and hip abduction. We implemented a bilevel optimization to predict a parameterized assistive torque that minimizes metabolic cost, with assisted muscle dynamics estimated via either effort-minimization simulations (minimizing muscle effort only) or synergy-informed simulations (minimizing muscle effort constrained to a synergy structure). We used experimental data from five unimpaired adults walking at their preferred speed and compared results descriptively between the two formulations within each subject. Assistance based on effort-minimization simulations shut down agonist muscle activations and overestimated peak assistive torque compared with experimental values. In contrast, constraining muscle controls to a synergy structure prevented non-physiological muscle shutdown and yielded assistive torques closer to those measured in human-in-the-loop experiments. This benefit was not observed equally across all assisted degrees of freedom or subjects, emerging only where no single synergy could be suppressed to unload the assisted muscles. Synergy weights can therefore be interpreted as joint-specific predictors of when simulations can reliably inform wearable robot design.

bioengineering↗
bioRxiv2026

Engineered microvessel networks -- Longitudinal transcriptomic profiling validates chip-grown tissues as a robust model for studying vasculature

Vascularised Organ-on-Chip (OoC) models are promising New Approach Methodologies (NAMs), but their translation requires validation for defined Contexts of Use (CoU). Here, we combine microfluidic microvessel networks (MVNs) with longitudinal bulk and single-cell RNA sequencing to determine how cell provenance influences engineered vascular phenotype. Stromal cell identity produced distinct network architectures and transcriptional trajectories, demonstrating that support cells, commonly treated as interchangeable, represent an important CoU variable. Primary human pancreatic microvascular endothelial cells failed to form stable perfusable networks, but supplementation with 10% Human Umbilical Vein Endothelial Cells (HUVECs) or Blood Outgrowth Endothelial Cells (BOECs) rescued self-assembly. Single-cell transcriptomics identified specialised endothelial populations associated with vascular morphogenesis, including tip, stalk, phalanx, endothelial to mesenchymal transition (EndMT) and pericyte-like endothelial cells. Failed networks lacked coherent endothelial specialisation, whereas rescued networks restored stabilising cell states and revealed FLRT2--UNC5B signalling within pericyte-like HUVECs, recapitulating a pathway implicated in angiogenic development in vivo. These findings establish cell provenance as a critical determinant of microvascular NAM performance and demonstrate how transcriptomic validation can define and strengthen the biological relevance of microvessel-on-chip models for specific CoUs.

bioengineering↗
bioRxiv2026

Benchmarking foundation models for resting-state functional magnetic resonance imaging time series in cognitive aging research

Foundation models trained on large neuroimaging datasets could help smaller studies investigate cognition from brain recordings. However, whether the foundation model-derived representations improve assessment of current cognition, prediction of follow-up cognition, or characterization of cognitive change remains unclear. We evaluated nine configurations from five model families that process regional resting-state functional magnetic resonance imaging time series, using 3,103 scans from 1,653 participants across two observational and five intervention aging cohorts. Primary frozen representations showed no consistent superiority over conventional functional connectivity for concurrent cognitive associations or diagnostic classification. Changing the readout improved selected concurrent cognitive associations without updating model weights, indicating that performance depended partly on how representations were extracted. Additional post-training and embedding alignment yielded gains in selected settings but did not consistently improve performance across outcomes. In the primary longitudinal analyses, imaging representations did not establish added value beyond baseline clinical measures. These findings show that readout choice influences concurrent cognitive associations, while the added value of these representations for longitudinal outcomes remains unestablished.

bioengineering↗